These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA. DiPaolo JA, Popescu NC, Alvarez L, Woodworth CD. Crit Rev Oncog; 1993; 4(4):337-60. PubMed ID: 8394744 [Abstract] [Full Text] [Related]
3. Comparative analysis of cervical cancer in women and in a human papillomavirus-transgenic mouse model: identification of minichromosome maintenance protein 7 as an informative biomarker for human cervical cancer. Brake T, Connor JP, Petereit DG, Lambert PF. Cancer Res; 2003 Dec 01; 63(23):8173-80. PubMed ID: 14678972 [Abstract] [Full Text] [Related]
5. Temporal and histologic relationships of proliferating cell nuclear antigen and human papillomavirus type 11 in the mouse xenograft system. Brown DR, Pratt L, Fife KH, Bryan JT. J Med Virol; 1996 Jan 01; 48(1):108-13. PubMed ID: 8825719 [Abstract] [Full Text] [Related]
8. High-risk human papillomavirus E7 oncoprotein detection in cervical squamous cell carcinoma. Ressler S, Scheiden R, Dreier K, Laich A, Müller-Holzner E, Pircher H, Morandell D, Stein I, Viertler HP, Santer FR, Widschwendter A, Even J, Jansen-Dürr P, Capesius C, Zwerschke W. Clin Cancer Res; 2007 Dec 01; 13(23):7067-72. PubMed ID: 18056184 [Abstract] [Full Text] [Related]
9. Induction of aromatase expression in cervical carcinomas: effects of endogenous estrogen on cervical cancer cell proliferation. Nair HB, Luthra R, Kirma N, Liu YG, Flowers L, Evans D, Tekmal RR. Cancer Res; 2005 Dec 01; 65(23):11164-73. PubMed ID: 16322267 [Abstract] [Full Text] [Related]
12. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA. Lu DW, El-Mofty SK, Wang HL. Mod Pathol; 2003 Jul 01; 16(7):692-9. PubMed ID: 12861066 [Abstract] [Full Text] [Related]
13. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner. López-Ocejo O, Viloria-Petit A, Bequet-Romero M, Mukhopadhyay D, Rak J, Kerbel RS. Oncogene; 2000 Sep 21; 19(40):4611-20. PubMed ID: 11030150 [Abstract] [Full Text] [Related]
14. [Development of HPV16 positive cervical cancer model in the hu-PBL-SCID mouse and its immunological features]. Liang ZX, Cheng Q, Chen HZ, Xie X, Ye DF. Zhonghua Yi Xue Za Zhi; 2004 Sep 02; 84(17):1465-9. PubMed ID: 15500747 [Abstract] [Full Text] [Related]
16. The relationship between c-FLIP expression and human papillomavirus E2 gene disruption in cervical carcinogenesis. Wang W, Wang S, Song X, Sima N, Xu X, Luo A, Chen G, Deng D, Xu Q, Meng L, Lu Y, Ma D. Gynecol Oncol; 2007 Jun 02; 105(3):571-7. PubMed ID: 17433827 [Abstract] [Full Text] [Related]
19. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix. Zielinski GD, Snijders PJ, Rozendaal L, Daalmeijer NF, Risse EK, Voorhorst FJ, Jiwa NM, van der Linden HC, de Schipper FA, Runsink AP, Meijer CJ. J Pathol; 2003 Dec 02; 201(4):535-43. PubMed ID: 14648656 [Abstract] [Full Text] [Related]